Topical minoxidil labels say results may appear at 2 to 4 months for men and 3 to 6 months for women, and the AAD suggests 6 to 12 months to judge. A brief shed early on is common, and benefits last only with continued use.
Topical hair regrowth treatments, led by minoxidil, work slowly. The FDA-approved labels say men may see results as early as 2 months, though some need at least 4, and women may see results at 3 months, though some need at least 6. The American Academy of Dermatology (AAD) suggests giving it about 6 to 12 months before deciding how well it works. Many people notice extra shedding in the first weeks, which the labels describe as expected and temporary, and any regrowth lasts only as long as you keep using the treatment.
Minoxidil is available without a prescription in 2% and 5% strengths, and the AAD notes both are FDA-approved for female pattern hair loss. The men's 5% foam is labeled to regrow hair on the top of the scalp (the crown, or vertex), and the label states it is not intended for a receding hairline or frontal baldness.
The AAD describes realistic goals: minoxidil can stimulate hair growth and help prevent further loss in early hair loss, but it cannot regrow a full head of hair. It also notes minoxidil tends to work better when combined with another hair loss treatment. Both product labels say plainly that the amount of regrowth differs from person to person and that the product will not work for everyone.
In a 48-week randomized trial of 393 men published in the Journal of the American Academy of Dermatology in 2002, 5% minoxidil outperformed both 2% minoxidil and placebo on hair counts and on patient and investigator ratings. The authors reported 45 percent more regrowth with 5% than with 2% at week 48, and an earlier response with the stronger solution. Itching and local irritation were more common with 5%. As with all trial results, these are averages, and individual results vary.
| Time since starting | What the labels and the AAD describe |
|---|---|
| First 2 to 8 weeks | Possible temporary increase in shedding |
| Around 2 to 4 months (men) | Earliest results per the men's label; some men need at least 4 months |
| Around 3 to 6 months (women) | Earliest results per the women's label; some women need at least 6 months |
| 6 to 12 months | The AAD's window for judging how well it works |
| Ongoing | Continued use is needed to keep any regrowth |
The labels explain why it takes so long: normal hair grows only about 1/2 to 1 inch per month, so regrowth also takes time. If there is no regrowth after 4 months (men's label) or 6 months (women's label), the labels advise stopping and seeking medical advice.
The men's foam leaflet says hair loss may increase temporarily for up to 2 weeks after starting, which it describes as "likely a sign that you are getting rid of old hairs in order to regrow more new hairs." The women's leaflet similarly notes hair loss may continue for up to 2 weeks. Both say to see a clinician if it continues beyond that. The AAD describes a somewhat longer window, saying a temporary increase in hair loss may occur during the first 2 to 8 weeks and stops as hair begins to regrow.
A 2025 review in SKIN The Journal of Cutaneous Medicine found that among hair loss treatments, shedding is best documented with topical and oral minoxidil. It is thought to happen because minoxidil pushes resting follicles into a new growth phase early, which releases the old resting hairs. The authors also note it could reflect stress-related shedding and that the phenomenon is still poorly defined in the research.
The practical point: an early shed is usually not a reason to stop. If it is heavy or lasts longer than the labels or your clinician describe, get it checked.
The labeling and the AAD describe the most common issues as local:
A 2025 meta-analysis in JAAD Reviews, covering 27 studies and 4,294 participants, found unwanted hair growth in 0 to 2 percent of people using topical minoxidil, compared with 10 to 33 percent across low-dose oral minoxidil groups. Very few people stopped because of it. The AAD suggests applying minoxidil only to the scalp and washing your face afterward to limit facial hair growth.
The labels also list reasons to stop and seek medical advice: chest pain, rapid heartbeat, faintness or dizziness, sudden unexplained weight gain, or swelling of the hands or feet. They advise asking a clinician first if you have heart disease, and they warn that the product may be harmful during pregnancy or breastfeeding; the AAD advises avoiding it in those situations. The foam is extremely flammable, so avoid fire, flame or smoking during and right after applying it. If you have chest pain or trouble breathing, call 911.
Some prescription topical solutions combine minoxidil with other ingredients. These compounded products are not FDA-approved, and the FDA notes there are no FDA-approved topical products containing finasteride. In 2025, the FDA warned about compounded topical finasteride after reports of side effects similar to oral finasteride, including sexual and mood effects that often persisted after stopping, and about the risk of transferring the product to others, especially women who are or may become pregnant.
NewDay Wellness offers a compounded, finasteride-free hair regrowth spray that combines minoxidil 7% with tretinoin 0.025%, fluocinolone 0.025% (a mild topical steroid), biotin and melatonin. It contains no finasteride, so the FDA's topical finasteride alert does not apply to it, but like all compounded products it is not FDA-approved, and the 7% strength is higher than the 2% and 5% strengths sold over the counter. A licensed provider can explain whether it or a single-ingredient FDA-approved product better fits you.
No. Both labels state that using more than directed will not improve results. The men's label adds that using it more often will not help either, and that continued, consistent use is what maintains regrowth.
The labels say continued use is needed to keep regrowth, or hair loss will begin again. The AAD notes that after stopping, hair gradually looks thinner and shedding increases.
In the 2002 trial in men, 5% produced more regrowth and an earlier response than 2%, with more itching and irritation. For women, the AAD notes both strengths are FDA-approved. A clinician can help you weigh effect against tolerability.
The labels say not to use it if your hair loss is sudden or patchy, if you have no family history of hair loss or if you do not know the cause. Those patterns can point to conditions that need a different evaluation.
A licensed provider can confirm what type of hair loss you have, review heart health and pregnancy plans, and set realistic expectations for any topical or oral treatment. Dosing and application are set by your prescriber or the product labeling. You can explore options on our Hair & Skin page. This article is educational and does not determine eligibility for any treatment.
Written by the NewDay Wellness editorial team from the sources above and checked against them before publication, and medically reviewed by Dr. Sean Arora and Dr. Shannon Arora of Arora Health & Aesthetics; see our editorial standards. This article is educational and does not diagnose conditions, establish eligibility for any medication, or replace care from a licensed provider. Compounded medications are not FDA-approved.
The most common cause of thinning hair in women is female pattern hair loss, a hereditary condition that often begins in midlife. Shedding after childbirth or illness, thyroid problems and anemia can look similar, so diagnosis comes first.
Read articleFor pattern hair loss, the FDA has approved topical minoxidil and oral finasteride (men only). Spironolactone and oral minoxidil are used off-label, and compounded topical blends are not FDA-approved. Here is how the categories differ.
Read articleTretinoin is a prescription retinoid FDA-approved to treat acne, and one low-strength cream is approved to help soften fine facial wrinkles. Expect dryness or peeling and possible early breakouts, with acne improvement usually taking 6 to 12 weeks.
Read article